Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a Single 40-mg posterior subtenon application

Ophthalmology

Volumn 117, Issue 12, 2010, Pages 2365-2371

  Shen, Lijun ^a   You, Yongsheng ^a   Sun, Shumao ^a   Chen, Yiqi ^a   Qu, Jia ^a   Cheng, Lingyun ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CHORIORETINOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; INTERVENTION STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUCOCORTICOIDS; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TANDEM MASS SPECTROMETRY; TENON CAPSULE; TRIAMCINOLONE ACETONIDE; VITREOUS BODY; YOUNG ADULT;

EID: 78649805271     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.033     Document Type: Article

References (38)

1. C.J. Helm, and G.N. Holland The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis Am J Ophthalmol 120 1995 55 64
2. M. Lafranco Dafflon, V.T. Tran, Y. Guex-Crosier, and C.P. Herbort Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects Graefes Arch Clin Exp Ophthalmol 237 1999 289 295
3. A.A. Okada, T. Wakabayashi, and Y. Morimura Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis Br J Ophthalmol 87 2003 968 971
4. R.P. Danis, T.A. Ciulla, L.M. Pratt, and W. Anliker Intravitreal triamcinolone acetonide in exudative age-related macular degeneration Retina 20 2000 244 250
5. Q. Mohamed, M.C. Gillies, and T.Y. Wong Management of diabetic retinopathy: a systematic review JAMA 298 2007 902 916
6. Diabetic Retinopathy Clinical Research Network (DRCR.net) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema Arch Ophthalmol 127 2009 245 251
7. M. Cellini, A. Pazzaglia, and E. Zamparini Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema BMC Ophthalmol [serial online] 8 2008 5 http://www.biomedcentral.com/1471-2415/8/5 Accessed March 3, 2010
8. M. Shimura, T. Nakazawa, and K. Yasuda Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema Br J Ophthalmol 91 2007 449 454
9. S. Ozdek, U.A. Bahceci, G. Gurelik, and B. Hasanreisoglu Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema J Diabetes Complications 20 2006 246 251
10. Z. Dong, K. Namba, and N. Kitaichi Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation Jpn J Ophthalmol 52 2008 374 379
11. S. Ozdek, Y.T. Deren, G. Gurelik, and B. Hasanreisoglu Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion Ophthalmic Res 40 2008 26 31
12. D.B. Roth, C. Cukras, and R. Radhakrishnan Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions Ophthalmic Surg Lasers Imaging 39 2008 446 454
13. I.L. McAllister, S. Vijayasekaran, S.D. Chen, and D.Y. Yu Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion Am J Ophthalmol 147 2009 838 846
14. S. Choudhry, and S. Ghosh Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema Clin Exp Ophthalmol 35 2007 713 718
15. J. Toda, H. Fukushima, and S. Kato Injection of triamcinolone acetonide into the posterior sub-Tenon capsule for treatment of diabetic macular edema Retina 27 2007 764 769
16. Y.S. Byun, and Y.H. Park Complications and safety profile of posterior subtenon injection of triamcinolone acetonide J Ocul Pharmacol Ther 25 2009 159 162
17. J.A. Cardillo, L.A. Melo Jr, and R.A. Costa Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema Ophthalmology 112 2005 1557 1563
18. M.A. Bonini-Filho, R. Jorge, and J.C. Barbosa Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial Invest Ophthalmol Vis Sci 46 2005 3845 3849
19. P.M. Beer, S.J. Bakri, and R.J. Singh Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 2003 681 686
20. J.O. Mason III, M.D. Somaiya, and R.J. Singh Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes Retina 24 2004 900 904
21. B.R. Kosobucki, W.R. Freeman, and L. Cheng Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye Br J Ophthalmol 90 2006 705 708
22. L. Cheng, A.S. Banker, and M. Martin Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection Ophthalmology 116 2009 1356 1359
23. S. Zaka-ur-Rab, S. Mahmood, and M. Shukla Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection Am J Ophthalmol 148 2009 414 419
24. S. Staudt, D.W. Miller, K. Unnebrink, and F.G. Holz Incidence and extent of postoperative macular edema following vitreoretinal surgery with and without combined cataract operation [in German] Ophthalmologe 100 2003 702 707
25. S.J. Kim, D.F. Martin, and G.B. Hubbard III Incidence of postvitrectomy macular edema using optical coherence tomography Ophthalmology 116 2009 1531 1537
26. E.R. Thomas, J. Wang, and E. Ege Intravitreal triamcinolone acetonide concentration after subtenon injection Am J Ophthalmol 142 2006 860 861
27. M. Inoue, K. Takeda, and K. Morita Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection Am J Ophthalmol 138 2004 1046 1048
28. D. Jaffuel, C. Roumestan, and P. Balaguer Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids Steroids 66 2001 597 604
29. S.P. Umland, D.K. Nahrebne, and S. Razac The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells J Allergy Clin Immunol 100 1997 511 519
30. O. Weijtens, F.A. van der Sluijs, and R.C. Schoemaker Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection Am J Ophthalmol 123 1997 358 363
31. K. Nan, S. Sun, and Y. Li Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection Br J Ophthalmol 94 2010 654 658
32. J.E. Riviere Comparative Pharmacokinetics: Principles, Techniques, and Applications J.E. Riviere, Interspecies Extrapolations 1999 Iowa State Press Ames, IA 296 307
33. C. Liapi, and G.P. Chrousos Glucocorticoids S.J. Yaffe, J.V. Aranda, Pediatric Pharmacology: Therapeutic Principles in Practice 2nd ed. 1992 Saunders Philadelphia, PA 466 475
34. J.A. Gusenoff, S.M. Harman, and J.D. Veldhuis Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men Am J Physiol Endocrinol Metab 280 2001 E616 E625
35. J. Toda, H. Fukushima, and S. Kato Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients Diabetes Res Clin Pract 84 2009 e38 e40
36. M.C. Gillies, J.M. Simpson, and W. Luo A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results Arch Ophthalmol 121 2003 667 673
37. J.E. Kim, J.S. Pollack, D.G. Miller ISIS Study Group ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema Retina 28 2008 735 740
38. A.M. Tammewar, L. Cheng, and O.R. Kayikcioglu Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections Br J Ophthalmol 92 2008 810 813